Published: Sep, 2016
The global immunoprotein diagnostic testing market is led by many global giants. Some of the players operating in the market are Abbott Laboratories, Inc., Abcam PLC, Enzo Life Sciences, Inc., DiaSorin SPA, and Fujirebio Diagnostics, Inc. The distributors in the market, supply products for more than one company. A few substitutes in the market such as molecular diagnostics and microbiology assay are available, but with their own disadvantages. Thus, the threat of substitutes is expected to be low, states a new report by Transparency Market Research (TMR).
High entry barriers such as compliance to regulations and huge capital requirements exist in the immunoprotein diagnostic testing market. However, the threat of new entrants is still expected to be moderate as many new players offer OEM services to the leading players in the market. These small companies can enter the market easily through forward integration.
According to the report, the global immunoprotein diagnostic testing market is expected to be worth US$15.35 bn by 2019. On the basis of assay technology used, the enzyme-based immunoassay segment is expected to lead in the market in the coming years. The market for enzyme-based immunoassay is projected to be worth US$5.34 bn by 2019.
North America to Lead Market owing to Need for Quick Diagnostic Services for Viral Infections and Cancer
By geography, North America is expected to lead in the market and be worth US$6.07 bn by 2019. The market in the region is driven by the demand for quick diagnostic services for viral infections and cancer. The rising trend of preventive healthcare is also creating new opportunities for the market in North America. Additionally, increasing cases of drug abuse and allergies have become major concerns in the U.S., which are further driving the demand for immunoprotein diagnostic testing.
By immunoprotein type, the immunoglobulin diagnostic tests segment is expected to lead in the global market in the coming years. The global market for immunoglobulin diagnostic testing is expected to be worth US$4.7 bn by 2019 owing to a wide scope of application in infectious disease testing, allergy testing, and autoimmune testing.
Rising Prevalence of Diseases to Create Need for Immunoprotein Diagnostic Testing
The rising prevalence of malaria, hepatitis, typhoid, HIV, tuberculosis, and cancer across the globe is driving the global immunoprotein diagnostic testing market. “Many of the diseases have a higher prevalence in underdeveloped economies,” states a TMR analyst. Thus, the demand for low cost, yet effective diagnostic tests is particularly high in underdeveloped nations. A need to diagnose diseases at an earlier stage to avoid severe complications is leading to an increased demand for immunoprotein diagnostic testing kits. Besides this, the market is gaining impetus from technological innovations. Advancements in technology have helped reduce the amount of sample required for tests and also enabled testing for multiple biomarkers in a single assay, reducing the cost per test.
High Cost of Diagnosis Dampening Demand for Immunoprotein Diagnostic Testing
Due to economic crisis, governments of countries such as Germany, France, Spain, Italy, and Hungary have cut down on reimbursement rates, which is increasing the out of pocket expenses of patients. This is limiting the adoption of immunoprotein diagnostic testing. Additionally, the low per capita income of people in many countries have led patients to look for cost effective alternatives for diagnosis. These factors are expected to dampen the demand for immunoprotein diagnostic testing.
Immunochromatography-based Cassette Kits to Emerge as Opportunity for Growth in Market
After the modification of the Clinical Laboratory Improvement Amendments (CLIA) waiver policies, the FDA has approved tests for home use. This has hugely benefitted the home diagnostics market, which is led by immunochromatography-based cassette kits such as pregnancy detection kits, HIV, malaria, and drug abuse testing kits. Additionally, the over-the-counter sale and wide availability of immunochromatography-based cassette kits are expected to drive the market further.
An increased investment in R&D in order to expand the application of the available technologies have led to the introduction of newer products. This has also led to the discovery of new biomarkers such as free light chains, which is acting as an opportunity to expand the scope of market.
This information is based on the findings of a report published by Transparency Market Research titled “Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2013 - 2019.”
The global immunoprotein diagnostic testing market is segmented as follows:
- Enzyme Based Immunoassay
- Chemiluminescence Assay
- Immunofluorescence Assay
- Immunoturbidity Assay
- Immunoprotein Electrophoresis
- Complement System Proteins Diagnostic Tests
- Free Light Chain Diagnostic Tests
- Haptoglobin Diagnostic Tests
- Immunoglobulin Diagnostic Tests
- Prealbumin Diagnostic Tests
- C-Reactive Protein (CRP) Diagnostic Tests
- Infectious Disease Testing
- Oncology Testing
- Endocrine Testing
- Toxicology Testing
- Allergy Testing
- Autoimmune Disease Testing
- North America
- Asia Pacific
- Rest of the World
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453